Fetal Gene Editing with Peptide Nucleic Acids Cures Beta-Thalassemia in Mice

Results from study using peptide nucleic acid gene editing in mouse model suggests technology could be used to treat genetic disorders in humans before birth.


About Robert Zinn

Robert Zinn, M.D., Ph.D. is a medical doctor, physician, and web entrepreneur, who, for over 15 years was employed by academic and research institutions and focused his clinical practices on very specialized patient populations, such as those with rare genetic diseases or rare cancers. He shares his knowledge through his website, NutritionTheory.org

View all posts by Robert Zinn →